engineeringevil.com
Reclassification recommendations for drug in ‘magic mushrooms’
Public Release: 26-Sep-2018 If phase III clinical trials are successful, researchers suggest categorizing the drug as schedule IV Johns Hopkins Medicine In an evaluation of the safety and abuse res…